ERBB2, GATA3, PIK3CA, MAP2K4, and other driver genes are either overexpressed considerably or expressed at low levels in specific subtypes, which indicates that these genes have essential significance in the formation and progression of tumors in these subtypes and may be used as subtype-determining markers and breast cancer treatment targets. The gene discussed is GATA3; the disease is breast carcinoma.